Rossi GN
Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
ArticleAyahuasca
Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis: A Single-Blind Feasibility Proof-of-Concept Trial.
ArticleIbogaine
Feasibility, safety and preliminary effects of ibogaine in patients with moderate and severe alcohol use disorder: a pilot, open-label study.
ArticleAyahuasca
Acute suicidal behavior following ayahuasca ingestion in a clinical trial setting: a case report.
ArticleAyahuasca
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial.
ArticleAyahuasca
Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users.
ArticleKetamine
Solvent-free parallel artificial liquid membrane extraction for drugs of abuse in plasma samples using LC-MS/MS.
ArticleIbogaine
Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview.
ArticlePsychedelics
Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic.
ArticleAyahuasca
Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial.
ArticlePsychedelics
Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach.
ArticleAyahuasca
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
ArticlePsilocybin
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.
ArticleAyahuasca
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability.
ArticleAyahuasca
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials.
ArticleAyahuasca
Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.
ArticlePsilocybin
Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.
ArticleAyahuasca
Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.
ArticleAyahuasca
Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies.
ArticlePsilocybin
The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.
ArticleAyahuasca
Essential oil-based dispersive liquid-liquid microextraction for the determination of N,N-dimethyltryptamine and β-carbolines in human plasma: A novel solvent-free alternative.
ArticlePsilocybin